{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(1)"],"submitter":["Banerjee R"],"journal":["Blood cancer journal"],"pagination":["162"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10625982"],"repository":["biostudies-literature"],"pubmed_title":["Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians."],"pmcid":["PMC10625982"],"pubmed_authors":["Banerjee R","Kaur G","Wang B","Mehra N","Rajkumar SV","McCaughan G","Cowan AJ","Anderson LD"],"additional_accession":[]},"is_claimable":false,"name":"Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Nov","modification":"2025-04-21T17:24:15.59Z","creation":"2025-02-19T01:52:42.978Z"},"accession":"S-EPMC10625982","cross_references":{"pubmed":["37926718"],"doi":["10.1038/s41408-023-00937-0"]}}